Potential Role of AT1 Receptor Blocker in Treatment of Cardiomyopathy

Shokei Mitsuyama

doi:10.1016/j.cardfail.2007.06.051

Potential Role of AT1 Receptor Blocker in Treatment of Cardiomyopathy

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2007.06.051 ◽

2007 ◽

Vol 13 (6) ◽

pp. S15

Author(s):

Shokei Mitsuyama

Keyword(s):

Potential Role ◽

At1 Receptor ◽

Receptor Blocker ◽

At1 Receptor Blocker

Download Full-text

Angiotensin II type 1 (AT1)-receptor blocker prevents impairment of endothelium-dependent cerebral vasodilation by acute cigarette smoking in rats

Journal of Cerebral Blood Flow & Metabolism ◽

10.1038/sj.jcbfm.9591524.0179 ◽

2005 ◽

Vol 25 (1_suppl) ◽

pp. S179-S179

Author(s):

Mami Iida ◽

Hiroki Iida ◽

Motoyasu Takenaka ◽

Hisayoshi Fujiwara ◽

Shuji Dohi

Keyword(s):

Angiotensin Ii ◽

Cigarette Smoking ◽

At1 Receptor ◽

Receptor Blocker ◽

At1 Receptor Blocker ◽

Cerebral Vasodilation

Download Full-text

Effects of adjuvant-induced arthritis on the ventral prostate of rats treated with angiotensin AT1 receptor blocker

Life Sciences ◽

10.1016/j.lfs.2020.117629 ◽

2020 ◽

Vol 252 ◽

pp. 117629

Author(s):

Emerson Souza da Rocha ◽

Fabiana de Campos Gomes ◽

Murilo Romano de Oliveira ◽

Ricardo Vinicius Bruneto ◽

Rodrigo Miranda Ramos Borges ◽

...

Keyword(s):

At1 Receptor ◽

Receptor Blocker ◽

Ventral Prostate ◽

At1 Receptor Blocker ◽

Adjuvant Induced Arthritis

Download Full-text

Effects of the AT1 receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome

Hypertension Research ◽

10.1038/hr.2009.224 ◽

2010 ◽

Vol 33 (3) ◽

pp. 263-268 ◽

Cited By ~ 7

Author(s):

Nobukazu Ishizaka ◽

Makiko Hongo ◽

Gen Matsuzaki ◽

Kyoko Furuta ◽

Kan Saito ◽

...

Keyword(s):

Metabolic Syndrome ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Rat Model ◽

Channel Blocker ◽

At1 Receptor ◽

Receptor Blocker ◽

At1 Receptor Blocker ◽

Accumulation Of Lipids

Download Full-text

AT1 receptor blocker azilsartan medoxomil normalizes plasma miR-146a and miR-342-3p in a murine heart failure model

Biomarkers ◽

10.1080/1354750x.2016.1204001 ◽

2016 ◽

Vol 22 (3-4) ◽

pp. 253-260 ◽

Cited By ~ 5

Author(s):

Manami Kaneko ◽

Tomoko Satomi ◽

Shuji Fujiwara ◽

Hidefumi Uchiyama ◽

Keiji Kusumoto ◽

...

Keyword(s):

Heart Failure ◽

At1 Receptor ◽

Receptor Blocker ◽

Failure Model ◽

At1 Receptor Blocker ◽

Heart Failure Model ◽

Azilsartan Medoxomil

Download Full-text

Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-glutathionylation of endothelial nitric oxide synthase — Beneficial effects of therapy with the AT1-receptor blocker telmisartan

Vascular Pharmacology ◽

10.1016/j.vph.2011.08.128 ◽

2012 ◽

Vol 56 (5-6) ◽

pp. 351-352

Author(s):

Maike Knorr ◽

Sebastian Steven ◽

Michael Hausding ◽

Swenja Kröller-Schuhmacher ◽

Matthias Oelze ◽

...

Keyword(s):

Nitric Oxide ◽

Endothelial Dysfunction ◽

Nitric Oxide Synthase ◽

Endothelial Nitric Oxide Synthase ◽

At1 Receptor ◽

Receptor Blocker ◽

At1 Receptor Blocker ◽

Beneficial Effects ◽

Oxide Synthase ◽

Endothelial Nitric Oxide

Download Full-text

Should increasing the dose or adding an AT1 receptor blocker follow a relatively low dose of ACE inhibitor initiated in acute myocardial infarction?

Cardiovascular Research ◽

10.1016/s0008-6363(03)00318-3 ◽

2003 ◽

Vol 58 (3) ◽

pp. 611-620 ◽

Cited By ~ 2

Author(s):

T Sugie

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Low Dose ◽

Ace Inhibitor ◽

At1 Receptor ◽

Receptor Blocker ◽

At1 Receptor Blocker

Download Full-text

Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination

Neuroscience Letters ◽

10.1016/j.neulet.2006.07.022 ◽

2006 ◽

Vol 406 (1-2) ◽

pp. 92-96 ◽

Cited By ~ 20

Author(s):

Tobias Engelhorn ◽

Arnd Doerfler ◽

Gerd Heusch ◽

Rainer Schulz

Keyword(s):

Infarct Size ◽

Reductase Inhibitor ◽

At1 Receptor ◽

Cerebral Infarct ◽

Receptor Blocker ◽

Hmg Coa Reductase ◽

At1 Receptor Blocker ◽

Hmg Coa Reductase Inhibitor ◽

Coa Reductase

Download Full-text

FLUVASTATIN ENHANCES THE INHIBITORY EFFECTS OF A SELECTIVE AT1 RECEPTOR BLOCKER, VALSARTAN, ON ATHEROSCLEROSIS IN APOLIPOPROTEIN E NULL MICE

Journal of Hypertension ◽

10.1097/00004872-200402001-00174 ◽

2004 ◽

Vol 22 (Suppl. 1) ◽

pp. S44

Author(s):

Masaru Iwai ◽

Z Li ◽

L Wu ◽

H W Liu ◽

R Chen ◽

...

Keyword(s):

Apolipoprotein E ◽

At1 Receptor ◽

Receptor Blocker ◽

Inhibitory Effects ◽

At1 Receptor Blocker

Download Full-text

Angiotensin II AT1 receptor blocker candesartan prevents the fast up-regulation of cerebrocortical benzodiazepine-1 receptors induced by acute inflammatory and restraint stress

Behavioural Brain Research ◽

10.1016/j.bbr.2012.03.041 ◽

2012 ◽

Vol 232 (1) ◽

pp. 84-92 ◽

Cited By ~ 5

Author(s):

Enrique Sánchez-Lemus ◽

Masaru Honda ◽

Juan M. Saavedra

Keyword(s):

Angiotensin Ii ◽

Restraint Stress ◽

At1 Receptor ◽

Receptor Blocker ◽

At1 Receptor Blocker

Download Full-text

ARTA: AT1-receptor blocker therapy in patients undergoing coronary artery bypass grafting

Clinical Research in Cardiology ◽

10.1007/s00392-008-0719-9 ◽

2008 ◽

Vol 98 (1) ◽

pp. 33-43 ◽

Cited By ~ 5

Author(s):

Markus Flesch ◽

Stephan Knipp ◽

Gerhard Kessler ◽

Hans-Joachim Geissler ◽

Parwis Massoudy ◽

...

Keyword(s):

Coronary Artery ◽

Coronary Artery Bypass Grafting ◽

Coronary Artery Bypass ◽

Artery Bypass ◽

At1 Receptor ◽

Receptor Blocker ◽

Bypass Grafting ◽

Blocker Therapy ◽

Artery Bypass Grafting ◽

At1 Receptor Blocker

Download Full-text